Affiliations: [a] Department of Neurology, University Medical School, Georg-August University Göttingen, Germany
| [b] Department of Neuropathology, University Medical School, Georg-August University Göttingen, Germany
| [c] Department of Psychiatry, Psychosomatic Medicine, and Psychotherapy, Goethe University, Frankfurt, Germany
Correspondence:
[*]
Correspondence to: Inga Zerr, MD, Department of Neurology, National Reference Center for TSE Surveillance, University Medical Center Göttingen, Robert-Koch Str. 40, D-37075 Göttingen, Germany. Tel.: +49 551 396636; Fax: +49 551 397020; E-mail: epicjd@med.uni-goettingen.de.
Abstract: Background: The polymorphism at codon 129 of the prion protein gene (PRNP) and the PrPSc types 1 and 2 belong to a molecular classification of sporadic Creutzfeldt-Jakob disease (sCJD) that correlates well with the clinical and neuropathological phenotype of sCJD. Objective: The aim of the study was to perform the first detailed evaluation of neuropsychological deficits in a large group of definite sCJD patients with known molecular subtype. Methods: We analyzed neuropsychological symptoms in a cohort of 248 sCJD patients with known M129 V polymorphism of PRNP and prion protein type. Results: Neuropsychological symptoms were very frequent in our patients (96%) and occurred as early as in the first third of the disease course. Besides amnesia and impaired attention (89% each), frontal lobe syndrome (75%), aphasia (63%), and apraxia (57%) were the most common neuropsychological deficits. There was no statistically significant difference with regard to frequency of neuropsychological symptoms between the subtypes. In MV2 and VV2 patients, the onset of neuropsychological symptoms was significantly later than in all other subtypes. Conclusion: We provide the first detailed analysis of neuropsychological symptoms in a large group of sCJD patients with known M129 V genotype and prion protein type. We suggest that the rate of progression of neuropsychological symptoms is subtype-specific. These data may improve the diagnosis in atypical sCJD subtypes.
